U.S. Banks Stock News

NYSE:GBX
NYSE:GBXMachinery

Greenbrier Companies Q1 2026 Margin Improvement Challenges Bearish Narratives On Profitability

Greenbrier Companies (GBX) opened fiscal Q1 2026 with revenue of US$706.1 million and basic EPS of US$1.18, alongside trailing twelve month revenue of US$3.1 billion and EPS of US$5.96 that sit against a net profit margin of 6.0% over the past year. Over recent quarters, the business has seen revenue move from US$875.9 million and EPS of US$1.77 in Q1 2025 through to US$759.5 million and EPS of US$1.19 in Q4 2025, giving investors a clearer view of how the latest print fits into a year of...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Tilray Brands (TLRY) Q2 Loss Widens To US$44.9 Million Testing Profitability Narratives

Tilray Brands (TLRY) just posted Q2 2026 results with revenue of US$217.5 million, a basic EPS loss of US$0.41, and net income loss of US$44.9 million, putting the focus squarely on how the income statement is evolving through the year. The company has seen quarterly revenue move between US$200.0 million and US$224.5 million over the past six reported periods, while basic EPS has ranged from a small loss of roughly US$0.00 to much larger quarterly losses in 2025 and 2026. This keeps attention...
NYSE:UMH
NYSE:UMHResidential REITs

Is UMH Properties (UMH) Attractively Priced After Mixed Multi Year Share Returns

If you are wondering whether UMH Properties is attractively priced or not, this article walks through the key numbers so you can judge the value for yourself. The share price recently closed at US$16.08, with returns of 1.1% over the last week, 5.2% over the last month, 1.1% year to date, 8.9% over three years, and 34.2% over five years, while the 1 year return sits at a 7.0% decline. Recent coverage has focused on UMH Properties' position within the real estate sector and how investors are...
NasdaqGS:ANGO
NasdaqGS:ANGOMedical Equipment

Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum

AngioDynamics (ANGO) is back on investors’ radar after its Med Tech platforms helped deliver stronger quarterly results, prompting management to raise full year revenue and profitability guidance while outlining an upcoming CEO transition. See our latest analysis for AngioDynamics. Even with the raised guidance and progress in Med Tech platforms, AngioDynamics’ 7 day share price return of 21.73% and 30 day share price return of 23.63% suggest recent momentum has faded, aligning with a 1 year...
NasdaqCM:BHRB
NasdaqCM:BHRBBanks

Undiscovered Gems in the US Market for January 2026

As the U.S. stock market continues to soar, with the S&P 500 reaching new all-time highs following a drop in unemployment rates, investors are keenly observing opportunities within the small-cap sector. In this dynamic environment, identifying promising stocks requires a focus on companies that can navigate economic shifts and capitalize on emerging trends.
NasdaqCM:ARBE
NasdaqCM:ARBEElectronic

Arbe Robotics (ARBE) Is Up 7.6% After Unveiling NVIDIA‑Powered AI Radar Platform for Hands‑Off Driving

Arbe Robotics recently announced at CES 2026 that it is combining its automotive-grade ultra‑HD radar with NVIDIA’s accelerated computing to create an AI-based perception platform designed for hands-off, eyes-off driving, featuring over 20,000 detections per frame and more than 300 meters of range in varied weather conditions. A distinctive aspect of this development is how the dense radar point cloud, processed on NVIDIA’s in-vehicle computing, is being used to build AI-based occupancy...